Significant Association of Alpha-Methylacyl-CoA Racemase Gene Polymorphisms with Susceptibility to Prostate Cancer: a Meta-Analysis |
Chen, Nan
(West China School of Medicine, West China Hospital, Sichuan University)
Wang, Jia-Rong (West China School of Medicine, West China Hospital, Sichuan University) Huang, Lin (West China School of Medicine, West China Hospital, Sichuan University) Yang, Yang (West China School of Medicine, West China Hospital, Sichuan University) Jiang, Ya-Mei (West China School of Medicine, West China Hospital, Sichuan University) Guo, Xiao-Jiang (West China School of Medicine, West China Hospital, Sichuan University) He, Ya-Zhou (West China School of Medicine, West China Hospital, Sichuan University) Zhou, Yan-Hong (Department of Laboratory Medicine, West China Hospital, Sichuan University) |
1 | Amankwah EK, Sellers TA, Park JY, (2012). Gene variants in the angiogenesis pathway and prostate cancer. Carcinogenesis, 33, 1259-69. DOI |
2 | Askari F, Parizi MK, Jessri M, Rashidkhani B (2014). Dietary patterns in relation to prostate cancer in Iranian Men: A Case-Control Study. Asian Pac J Cancer Prev, 15, 2159-63. DOI ScienceOn |
3 | Daugherty SE, Shugart YY, Platz EA, et al (2007). Polymorphic variants in alpha-methylacyl-CoA racemase and prostate cancer. Prostate, 67, 1487-97. DOI |
4 | Doolan G, Benke G, Giles G (2014). An update on occupation and prostate cancer. Asian Pac J Cancer Prev, 15, 501-16. DOI ScienceOn |
5 | Ferdinandusse S, Denis S, L IJ, et al (2000). Subcellular localization and physiological role of alpha-methylacyl-CoA racemase. J Lipid Res, 41, 1890-96. |
6 | FitzGerald LM, Thomson R, Polanowski A, et al (2008). Sequence variants of alpha-methylacyl-CoA racemase are associated with prostate cancer risk: a replication study in an ethnically homogeneous population. Prostate, 68, 1373-79. DOI |
7 | Jemal A, Bray F, Center MM, et al (2011). Global cancer statistics. CA Cancer J Clin, 61, 69-90. DOI |
8 | Jiang N, Zhu S, Chen J, Niu Y, Zhou L (2013). A-methylacyl- CoA racemase (AMACR) and prostate-cancer risk: a metaanalysis of 4,385 participants. PLoS One, 8, 74386. DOI |
9 | Lee SJ, Joung JY, Yoon H, et al (2013). Genetic variations of alpha -methylacyl-CoA racemase are associated with sporadic prostate cancer risk in ethnically homogenous Koreans. Biomed Res Int, 2013, 394285. |
10 | Lloyd MD, Yevglevskis M, Lee GL, et al (2013). alpha- Methylacyl-CoA racemase (AMACR): metabolic enzyme, drug metabolizer and cancer marker P504S. Prog Lipid Res, 52, 220-30. DOI |
11 | Mahmoud AM, Yang W, Bosland MC (2014). Soy isoflavones and prostate cancer: a review of molecular mechanisms. J Steroid Biochem Mol Biol, 140, 116-32. DOI |
12 | Mazzola CR, Ghoneim T, Shariat SF, (2011). Emerging biomarkers for the diagnosis, staging and prognosis of prostate cancer. Prog Urol, 21, 1-10. DOI |
13 | Ouyang B, Leung YK, Wang V, et al (2011). Alpha-Methylacyl-CoA racemase spliced variants and their expression in normal and malignant prostate tissues. Urology, 77, 249.e1-249.e7. |
14 | Wang YC, Xia SJ (2009). An update of biomarkers in prostate cancer tissue. Zhonghua Nan Ke Xue, 15, 1039-43. |
15 | Wright JL, Neuhouser ML, Lin DW, et al (2011). AMACR polymorphisms, dietary intake of red meat and dairy and prostate cancer risk. Prostate, 71, 498-506. DOI |
16 | Yang B, Chen WH, Wen XF, Liu H, Liu F (2013). Role of DNA repair-related gene polymorphisms in susceptibility to risk of prostate cancer. Asian Pac J Cancer Prev, 14, 5839-42. DOI ScienceOn |
17 | Zhang LL, Sun L, Zhu XQ, et al (2014). rs10505474 and rs7837328 at 8q24 cumulatively confer risk of prostate cancer in Northern Han Chinese. Asian Pac J Cancer Prev, 15, 3129-32. DOI ScienceOn |
18 | Zha S, Ferdinandusse S, Denis S, et al (2003). Alpha-methylacyl- CoA racemase as an androgen-independent growth modifier in prostate cancer. Cancer Res, 63, 7365-76. |
19 | Zheng SL, Chang BL, Faith DA, et al (2002). Sequence variants of alpha-methylacyl-CoA racemase are associated with prostate cancer risk. Cancer Res, 62, 6485-8. |